386 related articles for article (PubMed ID: 9223481)
21. Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay.
Olsen SJ; Sarid R; Chang Y; Moore PS
J Infect Dis; 2000 Jul; 182(1):306-10. PubMed ID: 10882613
[TBL] [Abstract][Full Text] [Related]
22. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus.
Glenn M; Rainbow L; Auradé F; Davison A; Schulz TF
J Virol; 1999 Aug; 73(8):6953-63. PubMed ID: 10400794
[TBL] [Abstract][Full Text] [Related]
23. ORF73 of herpesvirus Saimiri strain C488 tethers the viral genome to metaphase chromosomes and binds to cis-acting DNA sequences in the terminal repeats.
Verma SC; Robertson ES
J Virol; 2003 Dec; 77(23):12494-506. PubMed ID: 14610173
[TBL] [Abstract][Full Text] [Related]
24. A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA.
Canham M; Talbot SJ
J Gen Virol; 2004 Jun; 85(Pt 6):1363-1369. PubMed ID: 15166417
[TBL] [Abstract][Full Text] [Related]
25. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Renne R; Barry C; Dittmer D; Compitello N; Brown PO; Ganem D
J Virol; 2001 Jan; 75(1):458-68. PubMed ID: 11119614
[TBL] [Abstract][Full Text] [Related]
26. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter.
Sarid R; Wiezorek JS; Moore PS; Chang Y
J Virol; 1999 Feb; 73(2):1438-46. PubMed ID: 9882349
[TBL] [Abstract][Full Text] [Related]
27. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
[TBL] [Abstract][Full Text] [Related]
28. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
29. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
31. p53 inhibition by the LANA protein of KSHV protects against cell death.
Friborg J; Kong W; Hottiger MO; Nabel GJ
Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
[TBL] [Abstract][Full Text] [Related]
32. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.
Lin SF; Sun R; Heston L; Gradoville L; Shedd D; Haglund K; Rigsby M; Miller G
J Virol; 1997 Apr; 71(4):3069-76. PubMed ID: 9060668
[TBL] [Abstract][Full Text] [Related]
33. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells.
Burnside KL; Ryan JT; Bielefeldt-Ohmann H; Gregory Bruce A; Thouless ME; Tsai CC; Rose TM
Virology; 2006 Oct; 354(1):103-15. PubMed ID: 16879850
[TBL] [Abstract][Full Text] [Related]
34. Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8.
Kellam P; Bourboulia D; Dupin N; Shotton C; Fisher C; Talbot S; Boshoff C; Weiss RA
J Virol; 1999 Jun; 73(6):5149-55. PubMed ID: 10233979
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein.
Li M; MacKey J; Czajak SC; Desrosiers RC; Lackner AA; Jung JU
J Virol; 1999 Feb; 73(2):1341-9. PubMed ID: 9882339
[TBL] [Abstract][Full Text] [Related]
36. Open reading frame 26 of human herpesvirus 8 encodes a tetradecanoyl phorbol acetate- and butyrate-inducible 32-kilodalton protein expressed in a body cavity-based lymphoma cell line.
O'Neill E; Douglas JL; Chien ML; Garcia JV
J Virol; 1997 Jun; 71(6):4791-7. PubMed ID: 9151873
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma in Morocco: a pathological study with immunostaining for human herpesvirus-8 LNA-1.
Hbid O; Belloul L; Fajali N; Ismaili N; Duprez R; Tanguy M; Benomar H; Tahri el H; Gessain A; Huerre M
Pathology; 2005 Aug; 37(4):288-95. PubMed ID: 16194827
[TBL] [Abstract][Full Text] [Related]
38. The Kaposi' s sarcoma-associated herpesvirus latency-associated nuclear antigen.
Komatsu T; Barbera AJ; Ballestas ME; Kaye KM
Viral Immunol; 2001; 14(4):311-7. PubMed ID: 11792061
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Pan HY; Zhang YJ; Wang XP; Deng JH; Zhou FC; Gao SJ
J Virol; 2003 Sep; 77(18):9758-68. PubMed ID: 12941884
[TBL] [Abstract][Full Text] [Related]
40. Establishment of an ELISA to detect Kaposi's sarcoma-associated herpesvirus using recombinant ORF73.
Ouyang XX; Fu BS; Li BL; Zeng Y; Xu FH; Wang LD
Virol Sin; 2010 Jun; 25(3):168-76. PubMed ID: 20960290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
